Six years of work by Harm Reduction Therapeutics paid off today! The FDA has officially approved over-the-counter RiVive™ (naloxone HCl nasal spray 3 mg) for the emergency treatment of opioid overdose.

Share this video to help save lies that would otherwise be lost to opioid overdose: https://t.co/gmfMjkZslt Carry naloxone. Save lives. #StopOpioidOverdose #NaloxoneSavesLives #HarmReduction #PSA

We are one sponsor of the Ad Council's “It’s Gotta Be You” PSA to spread naloxone education as part of the Office of National Drug Control Policy (ONDCP) fentanyl awareness campaign:

Our work is guided by harm reduction principles. We advocate for and operating under practical strategies to reducing negative consequences associated with drug use.

We hope you’ll take a moment to learn how to use our compassionate dose FDA-approved OTC opioid overdose reversal medication, RiVive® Naloxone HCI Nasal Spray 3 mg, by watching our latest video:

Learn how to use naloxone, and carry it with you. You could save a life. An inspiring and lifesaving PSA from The Real Deal on Fentanyl.

https://t.co/GjF4zDbYXd

As a 501(c)(3) NFP, we are continuously seeking funding partners so that we may increase product donations or decrease the selling price of products for harm reduction organizations, public charities, and other local community groups. Learn how to become a funding partner today:

At HRT, we believe that over-the-counter naloxone that saves lives without creating unintended harm should not be a privilege reserved for a few; it should be a right afforded to all, especially those most at risk of losing their lives to a fatal overdose.

https://t.co/kr62jHLXkW

ReVive® Naloxone HCI Nasal Spray 3 mg is a compassionate dose naloxone product created for harm reductionist by harm reductionists. Learn how HRT is working to make naloxone available at a low-cost or free while supporting harm reduction from our founder and CEO Michael Hufford:

While the summit took place a few months ago, the importance of the discussions remains as crucial as ever. Learn more about the summit’s key highlights and takeaways:

The Compassionate Overdose Response Summit hosted in March discussed best practices in overdose prevention and engaged participants in a dialogue about naloxone dosing.

Remedy Alliance/For the People: https://t.co/VcSSKpUURT Prevention Point Pittsburgh: https://t.co/WZjRK1euiS National Harm Reduction Coalition: https://t.co/5LmEmdvzGk Drug Intervention Institute (DII): https://t.co/nlWFx3qehf #GivingTuesday #NaloxoneSavesLives

In the US, harm reduction orgs support communities in reducing negative consequences associated with drug use, like increasing access to lifesaving naloxone - opioid overdose reversal meds. Help put naloxone into the hands of those most at risk by making a donation to:

RiVive® naloxone HCI nasal spray 3 mg is an FDA-approved compassionate dose naloxone product created for harm reductionists by harm reductionists, made in the USA. Learn how to use RiVive® with these 5 key steps:

Remedy Alliance/For the People: https://t.co/VcSSKpUURT Prevention Point Pittsburgh: https://t.co/WZjRK1euiS National Harm Reduction Coalition: https://t.co/5LmEmdvzGk Drug Intervention Institute (DII):

Naloxone saves lives. Help get it to those most at risk by donating to underfunded community harm reduction organizations:

In the last 12 months over 81,000 people died in the US from overdoses involving opioids. Every one was preventable and each was someone who deserved a seat at the table.

Our work is guided by harm reduction principles like reducing negative consequences associated with drug use. We created RiVive® as a 3 mg naloxone product-strong enough to save lives while minimizing the unintended consequences of overdose reversal, like precipitated withdrawal.

Thanks to all who visited our booth and gave such a warm reception to FDA-approved OTC RiVive® (naloxone HCl nasal spray 3 mg), a compassionate dose emergency treatment of known or suspected opioid overdose created and made available for harm reductionists by harm reductionists.